TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic

PHASE4CompletedINTERVENTIONAL
Enrollment

280

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

December 31, 2008

Conditions
Kidney Transplantation
Interventions
DRUG

Tacrolimus

Administration Twice a day after adjustment to blood level

Trial Locations (10)

14033

CHU de la côté de Nacre, Caen

35033

CHU Rennes - Hôpital Pontchaillou, Rennes

37044

CHU Tours - Hôpital Bretonneau, Tours

51092

CHU Reims - Hôpital Maison Blanche, Reims

63003

CHU Gabriel Montpied, Clermont-Ferrand

67091

CHU Strasbourg - Hospices Civils, Strasbourg

76230

CHU Rouen - Hôpital de Bois-Guillaume, Bois-Guillaume

86021

CHU Poitiers- hôpital Jean Bernard, Poitiers

87042

CHU Limoges - Hôpital Dupuytren, Limoges

Unknown

CHU Angers, Angers

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

collaborator

Astellas Pharma Inc

INDUSTRY

lead

Centre Hospitalier Universitaire, Amiens

OTHER